Skip to main content
. Author manuscript; available in PMC: 2014 Aug 8.
Published in final edited form as: Cancer. 2013 Jun 6;119(15):2675–2682. doi: 10.1002/cncr.28130

Table 2b.

Disease-free survival multivariate analysis across all 3 treatment arms

Arm Covariate HR* 95% CI p-value

All sHER2 ≥15 1.95 1.52–2.50 <0.0001
Race 0.97 0.72–1.29 0.81
Menopausal Status 0.94 0.76–1.16 0.56
Histologic Tumor Grade 1.01 0.80–1.29 0.92
Tumor Size ≥ 2 cm 1.20 0.95–1.50 0.13
*

Stratified by hormone receptor status and nodal status.